Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

<i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies
Panelists provide considerations for the optimal approaches to diagnosing Pseudomonas infections and identify where imaging and rapid diagnostics fit into the paradigm.
Identifying Variables Predictive of HIV Acquisition in Electronic Health Records
Douglas Krakower, MD, discusses which variables in electronic health records could be used to identify candidates for pre-exposure prophylaxis.
Core Challenges in <i>Pseudomonas</i> Treatment Protocol
Marin Hristos Kollef, MD; Andrew Shorr, MD; Peter L. Salgo, M; and Jason Pogue, PharmD, BCPS-AQID, identify the core challenges present in the treatment protocol of Pseudomonas infections, such as nuances with the Centers for Medicare and Medicaid Services or end-of-life care.  
Exploring Appropriate Treatment Protocols for <i>Pseudomonas</i> Infections
Peter L. Salgo, MD; Marin Hristos Kollef, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; and Yoav Golan, MD, share insight on appropriate treatment protocols regarding Pseudomonas infections, specifically those concerning the value of treating a patient versus the safety of other patients.
Importance of Studying Ways to Improve Cognition In Women With HIV
Leah H. Rubin, PhD, MPH, MA, discusses the importance of finding ways to improve cognitive function in women who are living with HIV.
Electronic Health Record Data Expanding in Use to Identify Those at Risk of Diseases
Douglas Krakower, MD, explains how electronic health records have expanded in use in order to identify people at risk for diseases who could benefit from preventive interventions.
What Are Some of the Risk Factors for Augmented Renal Clearance?
Bruce A. Mueller, PharmD, explains the risk factors for augmented renal clearance.  
<i>Pseudomonas</i> Infections Continue to Acquire Resistance, Complicating Treatment
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; and Yoav Golan, MD, discuss Pseudomonas infections’ ability to evolve and acquire resistance to fluoroquinolones, polymyxins, aminoglycosides, and other such agents, complicating treatment approaches.
Big advances in treatment can